Evexia Lifecare Limited, established in 1990, has built a strong legacy over the years, evolving into a diversified business entity. The company was listed on the Bombay Stock Exchange (BSE) in 1994, under the stock code 524444, marking a significant milestone in its journey.
Initially, Evexia Lifecare ventured into various business sectors, including healthcare and wellness. The company developed and marketed a variety of products aimed at improving health, wellness, and nutrition. Over the years, Evexia expanded its reach and capabilities, gaining a reputation for quality in the health and wellness space.
However, since 2020, the company has made a strategic shift in its business focus. Recognizing the growing demand and potential in the pharmaceutical sector, Evexia pivoted its operations toward the pharmaceutical industry. Specifically, the company began focusing on the trading of pharmaceutical chemicals, forging key partnerships with prominent companies in South India.With this move, the company appears to be positioning itself for long-term success in the pharmaceutical trading space while continuing to build on its legacy of adaptability and business growth.
"To be a global leader in the healthcare and pharmaceutical sectors, driving innovation and delivering high-quality solutions that enhance the well-being of individuals and communities worldwide."
"To provide the highest quality pharmaceutical products and healthcare solutions by fostering strategic partnerships, embracing technological advancements, and staying dedicated to the health and wellness of our customers. We strive to deliver sustainable value to our stakeholders and contribute to a healthier, more vibrant world."
We Evexia Lifecare Limited into the trading of the Chemicals for more than a decade. The company is one of the leading company in trading of the industrial chemicals at large. We are mainly trading into Pharma chemicals. Which are mainly used in drugs. This trading business shares larger number of revenue of the company..
We combine advanced diagnostics, innovative treatments, and data-driven insights to empower individuals with customized care plans. Our mission is to enhance health outcomes by focusing on prevention, precision, and patient-centric approaches, ensuring every person receives the care they deserve.
under the expansion program of the company, the company was entered into Manufacturing of Plastic Granule Business in December 2019. Looking at the opportunity in the plastic waste segment, the company has decided to start the production of the reprocessing of plastic granules considering the HIGH demand of the same in the near area of HALOL.
Our state-of-the-art facilities and advanced technologies enable precise analysis for early detection, diagnosis, and monitoring of health conditions. Committed to supporting healthcare professionals and improving patient outcomes, we deliver reliable results with a focus on quality, innovation, and excellence in diagnostic care.